October 25th, 2022
Background
Central conventional chondrosarcoma (CS) is the most common primary malignant bone tumour in adults. Anatomical location, histopathology, and grading are the current criteria for determining treatment [1, 2], although providing prognoses…
August 12th, 2020
Jeffrey T. Kramer,President: Chondrosarcoma CS Foundation, Inc.
Introduction
Cancer patients and their families perceive physicians and oncologists as experts in the treatment of cancer. We rely on them for the answers we seek and to…
Read ArticleJuly 7th, 2020
John M. Gross, MDThe Johns Hopkins HospitalBaltimore, MD
President’s Note: John M. Gross, MD joined the Chondrosarcoma Foundation Board in May, 2020. During his transition from the Mayo Clinic in Rochester, MN to Johns Hopkins University in…
Mike SnyderAlbuquerque, New Mexico
You’ve just endured the difficult news that you or a loved one has chondrosarcoma, a rare form of bone cancer sometimes referred to as CS. And you suddenly find yourself dealing with an avalanche of…
Read Article